High Cholesterol: Mapping Unmet Need

Despite claims that millions of Americans could be eligible for treatment with a new class of cholesterol-lowering medications, called PCSK9 inhibitors, the fact is these new medicines will supplement – not replace – existing treatment options. PCSK9 inhibitors will help those who cannot be treated with existing cholesterol-lowering medicines.